News Tuoxin Pharmaceutical Group Co.,Ltd.

Equities

301089

CNE100004YC3

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
38.95 ^CNY	+0.33%		-8.80%	-27.88%

04-22	Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-22	Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-22	CI
Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-22	CI
Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23	CI
Tuoxin Pharmaceutical Group Co.,Ltd.(XSEC:301089) added to S&P Global BMI Index	18/09/23	CI
Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Approves the Cash Dividend for the Year 2022, Payment Date: 06 June 2023	31/05/23	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. has Changed its Name to Tuoxin Pharmaceutical Group Co., Ltd	26/05/23	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Approves the Cash Dividend for the Year 2022	18/05/23	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year of 2022	26/04/23	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25/04/23	CI
Xinxiang Tuoxin Pharma to Form New Chemical Products Subsidiary	17/03/23	MT
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	20/10/22	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22/08/22	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2021, Payable on May 25, 2022	18/05/22	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2021	17/05/22	CI
Tuoxin Pharmaceutical to Free Up 1.5 Million Shares For Trading; Shares Tank 5%	26/04/22	MT
Xinxiang Tuoxin Pharma’s 2021 Profit Plunges 42% as Sales Slip 5%	25/04/22	MT
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Proposes Final Dividend for 2021	22/04/22	CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	21/04/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Tuoxin Pharmaceutical Group Co.,Ltd.

Equities

301089

CNE100004YC3

Summary

Filters